BMS1P8

Across TCGA pan-cancer cohorts, BMS1P8 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated BMS1P8 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher BMS1P8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BMS1P8 expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.

LIHC, ACC, and READ are the cancer types where BMS1P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	All	0.469	0.613	<.001	78	view →
ACC	OS	Tertile	All	0.227	0.684	<.001	77	view →
READ	DFS	Tertile	III,IV	0.530	0.202	.013	40	view →
SKCM	OS	Median	All	0.412	0.276	.002	26	view →
BRCA	DFS	Tertile	IV	0.342	0.821	<.001	24	view →
SARC	OS	Quartile	All	0.772	0.867	.014	13	view →
LUSC	OS	Median	All	0.495	0.316	.001	12	view →
ESCA	OS	Quartile	III,IV	0.631	0.268	.018	11	view →
THYM	DFS	Median	III,IV	0.428	1.000	.002	10	view →
COAD	OS	Quartile	IV	0.287	0.688	.030	10	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	9	view →
KIRC	DFS	Quartile	III,IV	0.339	0.674	.008	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

BMS1P8–LIHC (DFS)

Open the LIHC breakdown →